Last reviewed · How we verify
NCT05272319
Genetic Collection Protocol
trial in Liver Diseases in 2,230 participants. Currently enrolling.
31 May 2029
Quick facts
| Lead sponsor | Arbor Research Collaborative for Health |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 2,230 |
| Start date | 6 April 2022 |
| Primary completion | 31 May 2029 |
| Estimated completion | 31 May 2029 |
| Sites | 13 locations across Canada, United States |
Conditions studied
- Liver Diseases — all drugs for Liver Diseases →
Sponsor
Arbor Research Collaborative for Health
Who can join
Adults 24 Hours to 25, any sex, with Liver Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study involves the one-time collection of whole blood or saliva samples for the extraction and storage of DNA for use in ongoing and future ChiLDReN studies.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05272319
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Liver Diseases
Currently open trials in the same condition.
- NCT07400289 — Development of a FibroScan Liver Examination Using a Single Probe · NA · recruiting
- NCT07150624 — The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine · Phase 4 · recruiting
- NCT06871111 — The Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) Trial · Phase 1 · recruiting
- NCT06874296 — Assessing Declined Liver Grafts With Normothermic Machine Perfusion to Reduce Transplant Waiting Time · NA · recruiting
- NCT07053488 — CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection · Phase 1, PHASE2 · recruiting
Other Arbor Research Collaborative for Health trials
Trials by the same sponsor.
- NCT04181138 — Primary Sclerosing Cholangitis in Children · recruiting
- NCT04970056 — Pancreatic Cancer Early Detection Consortium · recruiting
- NCT03350269 — Effect of Lost Wage Reimbursement to Kidney Donors on Living Donation Rates · NA · terminated
- NCT03808038 — Symptoms of Lower Urinary Tract Dysfunction Protocol 2/Recall Study · completed
- NCT02922751 — FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE) · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05272319 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Arbor Research Collaborative for Health
- Last refreshed: 10 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05272319.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing